Discerning the difference between some benign lesions and early stage breast cancer is a particularly challenging area of pathology, according to medical records and interviews with doctors and patients.

Diagnosing D.C.I.S. “is a 30-year history of confusion, differences of opinion and under- and overtreatment,” said Dr. Shahla Masood, the head of pathology at the University of Florida College of Medicine in Jacksonville. “There are studies that show that diagnosing these borderline breast lesions occasionally comes down to the flip of a coin.”

http://www.nytimes.com/2010/07/20/health/20cancer.html?_r=1&src=me&ref=homepage

The analysis included more than 35,000 postmenopausal women ages 50 to 76 who didn’t have breast cancer at the study outset. By the end of 2007, 880 of these women had developed breast cancer.

Women who reported taking fish oil at the start of the study were roughly half as likely to develop ductal carcinoma of the breast, the most common form of breast cancer, during the follow-up years. Women taking fish oil showed no reduced risk of the less-common lobular breast cancer. 

Other supplements showed no anticancer benefit in the new study. These included glucosamine, chondroitin, grapeseed, black cohosh, soy, dong quai, St. John’s wort, coenzyme Q10, garlic pills, ginkgo biloba, ginseng, melatonin, acidophilus and methylsulfonylmethane.

Read more at http://www.usnews.com/science/articles/2010/07/09/fish-oil-may-fight-breast-cancer.html

Researchers studied nearly 1,200 women with ductal carcinoma in situ (DCIS), a noninvasive and very early form of breast cancer confined to the milk ducts. They found that a combination of three tissue biomarkers was associated with a high risk of developing an invasive breast cancer with the potential to spread eight years later.

Also, DCIS that was diagnosed from a breast lump was linked to a greater risk of subsequent invasive cancer than DCIS that was diagnosed by mammography.
There’s still a long way to go before the personalized approach to treatment is ready for prime time.

http://www.webmd.com/breast-cancer/news/20100428/progress-in-predicting-invasive-breast-cancer

Stage 4 breast cancer is something I’ve had for 17 years. The average life expectancy with the diagnosis is 30 months, so this is a little like saying I’m 172 years old: seemingly impossible. But it’s not. I first found I had the illness in 1988, and it was rediagnosed as Stage 4 in 1993. That’s 22 years all together, which is the reason I post each year on the anniversary of the day I learned my cancer was back: to let women know that it happens, that people do live with this for years. http://www.nytimes.com/2010/04/27/health/27case.html?src=me&ref=homepage